Moreover, in transgenic mice models expressing human Tau mutations that evolve into tauopathies, i.e., P301L (Lewis et al., 2000) and P301S (Allen et al., 2002), SpCo is dramatically affected. This evidence concerns the gene MAPT and tauopathy.